Status:

COMPLETED

Neurological Effects of Acupuncture to Prevent Radiation-induced Xerostomia

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Head and Neck Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this clinical research study is to learn which areas of the brain respond to acupuncture that is designed to prevent xerostomia (dry mouth) in patients with head and neck cancer. Researche...

Detailed Description

Dry mouth is a common problem in cancer patients who have received radiation treatment to the head and neck. Acupuncture is a technique that may treat symptoms by inserting very thin, solid, sterile, ...

Eligibility Criteria

Inclusion

  • 18 years of age and be able to give informed consent.
  • Diagnosed with head and neck cancer, which will be primarily nasopharyngeal, and scheduled to undergo IMRT or proton with or without concurrent chemotherapy at MD Anderson or Fudan University.
  • Treatment plan that includes external beam radiation at a mean dose of at least 24 Gy or more to one of the parotid glands (the other gland can receive less than 24 Gy).
  • Anatomically intact parotid and submandibular glands.
  • Karnofsky performance status \> 60.
  • Must be right-handed.

Exclusion

  • History of xerostomia prior to head and neck radiation therapy or history of Sjögren's disease or another underlying systemic illness known to cause xerostomia.
  • Prior head and neck radiation treatment.
  • Suspected or confirmed physical closure of salivary gland ducts on either side.
  • Known bleeding disorders or taking any dose of warfarin or heparin.
  • Upper or lower extremity deformities (ie, missing limbs or scars that prevent needle insertion at the acupuncture points) that could interfere with accurate acupoint location or alter the energy pathway as defined by traditional acupuncture theory.
  • Local skin infections at or near the acupuncture sites or are under treatment for active systemic infection.
  • History of cerebrovascular accident or spinal cord injury since the mechanism of acupuncture may be associated with central nervous system activity.
  • Documented history of mental incapacitation or significant emotional or psychiatric disorder (i.e. bipolar, schizophrenia) that, in the opinion of the investigator, precludes study entry as these patients may not be able to cooperate with this slightly invasive procedure or with the data collection process.
  • Current acknowledged use of any illicit drugs or evidence of alcohol abuse as defined by The American Psychiatric Association criteria.
  • Patients who are currently receiving acupuncture for any condition or if they have ever had acupuncture before.

Key Trial Info

Start Date :

November 10 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 30 2022

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT02292368

Start Date

November 10 2014

End Date

August 30 2022

Last Update

September 1 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Texas MD Anderson Cancer Center

Houston, Texas, United States, 77030

2

Fudan University Cancer Hospital

Shanghai, China, 200433